Pressure BioSciences, Inc. Quarterly report pursuant to Section 13 or 15(d)

3. Summary of Significant Accounting Policies (Details 3)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Summary Of Significant Accounting Policies Details 3
Stock options	3,406,250pbio_StockOptions	1,730,750pbio_StockOptions
Convertible debt	8,555,938pbio_ConvertibleDebtDilutiveSecurities	932,500pbio_ConvertibleDebtDilutiveSecurities
Common stock warrants	19,182,201pbio_CommonStockWarrants	18,222,827pbio_CommonStockWarrants
Convertible preferred stock:
Series D Convertible Preferred stock	750,000pbio_SeriesDConvertiblePreferred	750,000pbio_SeriesDConvertiblePreferred
Series G Convertible Preferred stock	865,700pbio_SeriesGConvertiblePreferred	1,453,200pbio_SeriesGConvertiblePreferred
Series H Convertible Preferred stock	1,000,000pbio_SeriesHConvertiblePreferred	1,000,000pbio_SeriesHConvertiblePreferred
Series H2 Convertible Preferred stock	2,100,000pbio_SeriesHTwoConvertiblePreferred
Series J Convertible Preferred stock	3,546,000pbio_SeriesJConvertiblePreferred	5,087,500pbio_SeriesJConvertiblePreferred
Series K Convertible Preferred stock	11,416,000pbio_SeriesKConvertiblePreferred	10,729,000pbio_SeriesKConvertiblePreferred
Total potentially dilutive shares	50,822,089pbio_TotalPotentiallyDilutiveShares	39,905,777pbio_TotalPotentiallyDilutiveShares